vs
OnKure Therapeutics, Inc.（OKUR）与Arcadia Biosciences, Inc.（RKDA）财务数据对比。点击上方公司名可切换其他公司
Arcadia Biosciences, Inc.的季度营收约是OnKure Therapeutics, Inc.的1.1倍（$901.0K vs $802.0K），Arcadia Biosciences, Inc.净利率更高（-148.3% vs -1832.8%，领先1684.5%），OnKure Therapeutics, Inc.同比增速更快（1922.7% vs -25.8%）
OnKure Therapeutics是一家处于临床阶段的生物技术企业，专注于精准肿瘤疗法研发，主打产品为靶向小分子药物，包括表观遗传抑制剂、激酶抑制剂等，用于治疗难治性实体瘤与血液肿瘤，满足相关患者未被覆盖的医疗需求。
阿卡迪亚生物科学是一家美国上市农业生物技术企业，总部位于加利福尼亚州戴维斯，专注于开发可提升作物品质与产量的作物性状改良技术，该公司部分股权归道德指南针公司所有。
OKUR vs RKDA — 直观对比
营收规模更大
RKDA
是对方的1.1倍
$802.0K
营收增速更快
OKUR
高出1948.6%
-25.8%
净利率更高
RKDA
高出1684.5%
-1832.8%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $802.0K | $901.0K |
| 净利润 | $-14.7M | $-1.3M |
| 毛利率 | — | 21.4% |
| 营业利润率 | -1932.8% | -152.8% |
| 净利率 | -1832.8% | -148.3% |
| 营收同比 | 1922.7% | -25.8% |
| 净利润同比 | -27.2% | 67.1% |
| 每股收益（稀释后） | $-1.09 | $-0.97 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OKURRKDA
| Q4 25 | — | $901.0K | ||
| Q3 25 | $802.0K | $1.3M | ||
| Q2 25 | $934.0K | $1.5M | ||
| Q1 25 | — | $1.2M | ||
| Q4 24 | — | $1.2M | ||
| Q3 24 | $-44.0K | $1.5M | ||
| Q2 24 | — | $1.3M | ||
| Q1 24 | — | $987.0K |
净利润OKURRKDA
| Q4 25 | — | $-1.3M | ||
| Q3 25 | $-14.7M | $856.0K | ||
| Q2 25 | $-15.4M | $-4.5M | ||
| Q1 25 | — | $2.6M | ||
| Q4 24 | — | $-4.1M | ||
| Q3 24 | $-11.6M | $-1.6M | ||
| Q2 24 | — | $1.1M | ||
| Q1 24 | — | $-2.4M |
毛利率OKURRKDA
| Q4 25 | — | 21.4% | ||
| Q3 25 | — | 32.1% | ||
| Q2 25 | — | 43.4% | ||
| Q1 25 | — | 43.2% | ||
| Q4 24 | — | 31.9% | ||
| Q3 24 | — | 32.9% | ||
| Q2 24 | — | 51.5% | ||
| Q1 24 | — | 52.3% |
营业利润率OKURRKDA
| Q4 25 | — | -152.8% | ||
| Q3 25 | -1932.8% | -88.5% | ||
| Q2 25 | -1747.8% | -34.4% | ||
| Q1 25 | — | 44.2% | ||
| Q4 24 | — | -187.7% | ||
| Q3 24 | 26163.6% | -114.5% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -160.9% |
净利率OKURRKDA
| Q4 25 | — | -148.3% | ||
| Q3 25 | -1832.8% | 65.7% | ||
| Q2 25 | -1647.8% | -306.4% | ||
| Q1 25 | — | 216.6% | ||
| Q4 24 | — | -334.5% | ||
| Q3 24 | 26263.6% | -104.9% | ||
| Q2 24 | — | 81.2% | ||
| Q1 24 | — | -245.5% |
每股收益（稀释后）OKURRKDA
| Q4 25 | — | $-0.97 | ||
| Q3 25 | $-1.09 | $0.62 | ||
| Q2 25 | $-1.14 | $-3.26 | ||
| Q1 25 | — | $1.90 | ||
| Q4 24 | — | $-2.99 | ||
| Q3 24 | $-36.55 | $-1.18 | ||
| Q2 24 | — | $0.78 | ||
| Q1 24 | — | $-1.78 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $70.3M | $4.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $66.4M | $4.1M |
| 总资产 | $72.8M | $6.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资OKURRKDA
| Q4 25 | — | $4.6M | ||
| Q3 25 | $70.3M | $5.9M | ||
| Q2 25 | $83.4M | $4.4M | ||
| Q1 25 | — | $3.2M | ||
| Q4 24 | — | $4.2M | ||
| Q3 24 | $76.7M | $6.6M | ||
| Q2 24 | — | $8.1M | ||
| Q1 24 | — | $8.5M |
股东权益OKURRKDA
| Q4 25 | — | $4.1M | ||
| Q3 25 | $66.4M | $5.4M | ||
| Q2 25 | $78.2M | $4.5M | ||
| Q1 25 | — | $8.9M | ||
| Q4 24 | — | $6.2M | ||
| Q3 24 | $-135.1M | $10.3M | ||
| Q2 24 | — | $11.7M | ||
| Q1 24 | — | $10.6M |
总资产OKURRKDA
| Q4 25 | — | $6.5M | ||
| Q3 25 | $72.8M | $8.6M | ||
| Q2 25 | $86.1M | $7.8M | ||
| Q1 25 | — | $13.0M | ||
| Q4 24 | — | $13.5M | ||
| Q3 24 | $77.6M | $15.2M | ||
| Q2 24 | — | $17.4M | ||
| Q1 24 | — | $16.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-13.0M | $-861.0K |
| 自由现金流经营现金流 - 资本支出 | $-13.0M | — |
| 自由现金流率自由现金流/营收 | -1626.3% | — |
| 资本支出强度资本支出/营收 | 0.7% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流OKURRKDA
| Q4 25 | — | $-861.0K | ||
| Q3 25 | $-13.0M | $-257.0K | ||
| Q2 25 | $-13.3M | $-2.0M | ||
| Q1 25 | — | $-1.6M | ||
| Q4 24 | — | $-2.2M | ||
| Q3 24 | $-10.7M | $-1.8M | ||
| Q2 24 | — | $-2.5M | ||
| Q1 24 | — | $-3.2M |
自由现金流OKURRKDA
| Q4 25 | — | — | ||
| Q3 25 | $-13.0M | — | ||
| Q2 25 | $-13.3M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-10.7M | — | ||
| Q2 24 | — | $-2.5M | ||
| Q1 24 | — | $-3.2M |
自由现金流率OKURRKDA
| Q4 25 | — | — | ||
| Q3 25 | -1626.3% | — | ||
| Q2 25 | -1422.6% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 24270.5% | — | ||
| Q2 24 | — | -188.3% | ||
| Q1 24 | — | -326.5% |
资本支出强度OKURRKDA
| Q4 25 | — | 0.0% | ||
| Q3 25 | 0.7% | 0.0% | ||
| Q2 25 | 1.4% | 0.0% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | -40.9% | 0.0% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 1.3% |
现金转化率OKURRKDA
| Q4 25 | — | — | ||
| Q3 25 | — | -0.30× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.61× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -2.31× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
